65862-055Level 3
Lamivudine (Lamivudine)
**Product type:** Human Prescription Drug
**Active ingredient:** LAMIVUDINE
**Strength:** 10 mg/mL
**Dosage form:** Solution
**Route:** Oral
**Labeler:** Aurobindo Pharma Limited
**Marketing category:** ANDA (ANDA077695)
**Pharmacologic class:** Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/65862-055Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.